Fukui K, Kawashima Y, Iizumi H, Utsumi H, Nakajima T
Department of Psychiatry, Kyoto Prefectural University of Medicine, Japan.
Neuroreport. 1995 Mar 7;6(4):626-8. doi: 10.1097/00001756-199503000-00010.
Phencyclidine (PCP) is a dissociative drug and has been known to be an antagonist of N-methyl-D-aspartate (NMDA) receptor. We examined possible effects of acute treatment with PCP on neuropeptide Y (NPY) immunoreactive nerve fibres and cell bodies in rat forebrain by immunocytochemistry combined with morphometric analysis. Following the treatment, significant alterations were observed throughout the cerebral cortex, compared with controls. NPY-positive perikarya were increased in number (178%) whereas NPY-positive fibres and terminals were decreased in area (38%). The result suggests that the cortical NPY neuronal system is controlled, at least partly, by glutamatergic inputs via NMDA receptor-mediated mechanisms.